Skinvisible SKVI
OTC SKVI
$0.20 -0.23 (-53.49%)
At close: Sep 4, 2026 · 4:00 PM EDT

Skinvisible (SKVI) EPS (Basic) (2010 - 2026)

Skinvisible's (SKVI) quarterly EPS (Basic) came in at -$0.05 in Q2 2026, up 8.4% year-over-year from -$0.04 in Q2 2025, and up 4.36% quarter-over-quarter from -$0.05 in Q1 2026.

Analysis

Skinvisible (SKVI) EPS (Basic) (2010 - 2026) Analysis & Trends

Skinvisible has disclosed EPS (Basic) across 17 years of filings, most recently posting -$0.05 for Q2 2026.

  • In Q2 2026, EPS (Basic) rose 8.4% year-over-year to -$0.05; the TTM figure through Jun 2026 stood at -$0.19 (up 15.47% YoY), while the FY2025 annual figure was -$0.2, up 20.36% from the prior year.
  • EPS (Basic) came in at -$0.05 for Q2 2026 at Skinvisible, up from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.05 in Q2 2022 to a low of -$0.33 in Q1 2023.
  • Average EPS (Basic) over 5 years is -$0.08, with a median of -$0.06 recorded in 2023.
  • Year-over-year, EPS (Basic) tumbled 310.46% in 2023 and jumped 80.83% in 2024.
  • Over 5 years, EPS (Basic) stood at -$0.09 in 2022, then grew by 25.7% to -$0.07 in 2023, then retreated by 8.48% to -$0.07 in 2024, then soared by 34.02% to -$0.05 in 2025, then rose by 1.28% to -$0.05 in 2026.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$0.05 in Q2 2026, -$0.05 in Q1 2026, and -$0.05 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 2.30
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 2.04
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -0.54
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 1.68
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -0.04
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 0.33
7 Revolution Medicines 45.00 Bn 45.00 Bn - -3.06
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 2.92
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 7.82
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 -0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.05
Mar 31, 2026 -0.05
Dec 31, 2025 -0.05
Sep 30, 2025 -0.05
Jun 30, 2025 -0.05
Mar 31, 2025 -0.05
Dec 31, 2024 -0.07
Sep 30, 2024 -0.06
Jun 30, 2024 -0.07
Mar 31, 2024 -0.06
Dec 31, 2023 -0.07
Sep 30, 2023 -0.06
Jun 30, 2023 -0.06
Mar 31, 2023 -0.33
Dec 31, 2022 -0.09
Sep 30, 2022 -0.09
Jun 30, 2022 -0.05
Mar 31, 2022 -0.08
Dec 31, 2021 -0.10
Sep 30, 2021 -0.04